πŸ‡ΊπŸ‡Έ FDA
Patent

US 10085986

Pyrimidinone compounds and their use

granted A61KA61K31/513A61K45/06

Quick answer

US patent 10085986 (Pyrimidinone compounds and their use) held by Takeda Pharmaceutical Company Limited expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/513, A61K45/06, A61P, A61P25/04